Literature DB >> 11351303

Expression profiling of gastric adenocarcinoma using cDNA array.

W El-Rifai1, H F Frierson, J C Harper, S M Powell, S Knuutila.   

Abstract

To investigate the expression profile of gastric adenocarcinoma, cDNA array experiments were performed using Atlas Human Cancer 1.2 K Array (Clontech Laboratories, Palo Alto, CA) on nine xenografted and two primary gastric cancer samples. The expression of the tumor samples was compared to that of two normal gastric epithelial tissues. The expression pattern of the primary tumors was similar to that of xenografted tumors. The up-regulated genes had expression ratios ranging from 2.5 to 16, whereas the down-regulated genes had a range from -2.5 to -16. No variation in gene expression was detected in the analysis of the xenografted tumors versus the primary tumors, indicating that the xenografts represented the primary tumors well. Thirty-eight genes showed altered gene expression in 5 or more samples (>45%). Thirty-one genes were up-regulated and seven genes were down-regulated. The most abundantly up-regulated genes (ratio >5) included genes such as S100A4, CDK4, MMP14 and beta catenin. The GIF was markedly down-regulated (ratio < -10). To confirm our findings, six genes (three up- and three down-regulated) were selected for semi-quantitative RT-PCR analysis. The RT-PCR results were consistent with the array findings. Our approach revealed that several genes are abnormally expressed in gastric cancer and found that genes known to interact in several common molecular pathway(s) were consistently altered. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11351303     DOI: 10.1002/ijc.1264

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.

Authors:  Alexander R Novotny; Christoph Schuhmacher; Raymonde Busch; Michael W Kattan; Murray F Brennan; Jörg Rüdiger Siewert
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form.

Authors:  Puja Pathuri; Lutz Vogeley; Hartmut Luecke
Journal:  J Mol Biol       Date:  2008-05-07       Impact factor: 5.469

4.  Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability.

Authors:  Karolin Trautmann; Christine Steudel; Dana Grossmann; Daniela Aust; Gerhard Ehninger; Stephan Miehlke; Christian Thiede
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip.

Authors:  Chuan-Ding Yu; Shen-Hua Xu; Hang-Zhou Mou; Zhi-Ming Jiang; Chi-Hong Zhu; Xiang-Lin Liu
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

6.  Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis.

Authors:  Daisuke Kobayashi; Shuji Nomoto; Yasuhiro Kodera; Michitaka Fujiwara; Masahiko Koike; Goro Nakayama; Norifumi Ohashi; Akimasa Nakao
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

Review 7.  Microarray analysis in gastric cancer: a review.

Authors:  Giovanna D'Angelo; Teresa Di Rienzo; Veronica Ojetti
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

8.  Clustering of molecular alterations in gastroesophageal carcinomas.

Authors:  Natalie Koon; Alexander Zaika; Christopher A Moskaluk; Henry F Frierson; Sakari Knuutila; Steven M Powell; Wa'el El-Rifai
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

9.  Molecular targets for tumour progression in gastrointestinal stromal tumours.

Authors:  N Koon; R Schneider-Stock; M Sarlomo-Rikala; J Lasota; M Smolkin; G Petroni; A Zaika; C Boltze; F Meyer; L Andersson; S Knuutila; M Miettinen; W El-Rifai
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.

Authors:  Peter T Simpson; Balvinder S Shoker; Roger Barraclough; Nigel Halliwell; Philip S Rudland; D Ross Sibson; Michael P A Davies
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.